Ok Biotech Co., Ltd. Statistics
Ok Biotech Co., Ltd. (4155) Stock Statistics & Valuation Metrics
Total Valuation
Ok Biotech Co., Ltd. has a market cap or net worth of TWD 2.24B. The enterprise value is TWD 2.84B.
- Market Cap
- TWD 2.24B
- Enterprise Value
- TWD 2.84B
Share Statistics
Ok Biotech Co., Ltd. has 125,187,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 125,187,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.12%
Financial Efficiency
Ok Biotech Co., Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 2.77%.
- Return on Equity (ROE)
- 0.03
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 2.77%
- Return on Capital Employed (ROCE)
- 0.03
- Revenue Per Employee
- 25.10M
- Profits Per Employee
- 1.33M
- Employee Count
- 62
- Asset Turnover
- 0.40
- Inventory Turnover
- 2.47
Valuation Ratios
The current PE Ratio of Ok Biotech Co., Ltd. is 10.82. Ok Biotech Co., Ltd.’s PEG ratio is 0.01.
- PE Ratio
- 10.82
- PS Ratio
- 1.46
- PB Ratio
- 1.04
- Price to FCF
- 8.74
- Price to Operating Cash Flow
- 5.32
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Ok Biotech Co., Ltd. had revenue of 1.56B and earned 82.45M in profits. Earnings per share was 0.58.
- Revenue
- 1.56B
- Gross Profit
- 429.25M
- Operating Income
- 107.89M
- Pretax Income
- 103.87M
- Net Income
- 82.45M
- EBITDA
- 201.51M
- Earnings Per Share (EPS)
- 0.58
Cash Flow
In the last 12 months, operating cash flow was 490.95M and capital expenditures -233.49M, giving a free cash flow of 257.46M billion.
- Operating Cash Flow
- 490.95M
- Free Cash Flow
- 257.46M
- Free Cash Flow per Share
- 1.83
Dividends & Yields
Ok Biotech Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 1.68%
- Dividend Per Share
- ―
- Dividend Yield
- 1.68%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 11.44%
- Earnings Yield
- 9.28%
Stock Price Statistics
- Beta
- 0.04
- 52-Week Price Change
- 14.60%
- 50-Day Moving Average
- 15.37
- 200-Day Moving Average
- 14.75
- Relative Strength Index (RSI)
- 67.45
- Average Volume (3m)
- 497.24K
Important Dates
Ok Biotech Co., Ltd. upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 11, 2026
- Next Earnings Date
- Nov 17, 2026
- Ex-Dividend Date
- ―
Financial Position
Ok Biotech Co., Ltd. as a current ratio of 2.28, with Debt / Equity ratio of 41.14%
- Current Ratio
- 2.28
- Quick Ratio
- 1.45
- Debt to Market Cap
- 0.34
- Net Debt to EBITDA
- 3.57
- Interest Coverage Ratio
- 9.88
Taxes
In the past 12 months, Ok Biotech Co., Ltd. has paid 6.74M in taxes.
- Income Tax
- 6.74M
- Effective Tax Rate
- 0.06
Enterprise Valuation
Ok Biotech Co., Ltd. EV to EBITDA ratio is 8.18, with an EV/FCF ratio of 11.36.
- EV to Sales
- 1.90
- EV to EBITDA
- 8.18
- EV to Free Cash Flow
- 11.36
- EV to Operating Cash Flow
- 5.96
Balance Sheet
Ok Biotech Co., Ltd. has TWD 382.88M in cash and marketable securities with TWD 1.04B in debt, giving a net cash position of -TWD 661.17M billion.
- Cash & Marketable Securities
- TWD 382.88M
- Total Debt
- TWD 1.04B
- Net Cash
- -TWD 661.17M
- Net Cash Per Share
- -TWD 5.28
- Tangible Book Value Per Share
- TWD 15.00
Margins
Gross margin is 31.13%, with operating margin of 14.31%, and net profit margin of 15.76%.
- Gross Margin
- 31.13%
- Operating Margin
- 14.31%
- Pretax Margin
- 19.07%
- Net Profit Margin
- 15.76%
- EBITDA Margin
- 23.25%
- EBIT Margin
- 17.27%
Analyst Forecast
The average price target for Ok Biotech Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -10.90%
- EPS Growth Forecast
- ―
